Successful Treatment of Resistant Antiglomerular Basement Membrane Antibody Positivity with Mycophenolic Acid

スポンサーリンク

概要

• 論文の詳細を見る

• Anti-glomerular basement membrane (GBM) antibody disease may progress to end-stage renal failure, requiring either dialysis or renal transplantation. In patients with end-stage renal disease (ESRD) due to anti-GBM-ab disease, the recurrence rate after transplantation is as high as 50% (2) and delaying renal transplantation until circulating anti-GBM antibody levels have been undetectable for at least 12 months reduces the recurrence rate to 5-15%. We report a case of ESRD due to renal limited anti-GBM disease with circulating anti-GBM-ab resistant to standard treatment approach who achieved undetectable anti-GBM-ab with mycophenolic acid.

著者

• Alper Kiykim

  Department of Internal Medicine, Division of Nephrology, Mersin Universitiy, School of Medicine

• Horoz Mehmet

  Department of Internal Medicine, Division of Nephrology, Mersin Universitiy, School of Medicine

• Gok Ebru

  Department of Internal Medicine, Division of Nephrology, Mersin Universitiy, School of Medicine

関連論文

• Successful Treatment of Resistant Antiglomerular Basement Membrane Antibody Positivity with Mycophenolic Acid
• Crataegus Orientalis Associated Multiorgan Hypersensitivity Reaction and Acute Renal Failure

スポンサーリンク